Evidence map›Paper›PMID 36265932›Full record

ReviewJACC. Cardiovascular interventions2022

Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock.

Abdulla A Damluji, Behnam Tehrani, Shashank S Sinha, Marc D Samsky, Timothy D Henry, Holger Thiele, Nick E J West, Fortunato F Senatore, Alexander G Truesdell, George D Dangas and 9 more

Abstract readReviewConsensus Statement
In one paragraph

Review in JACC. Cardiovascular interventions, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 21 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
21citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

21 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. SCAI/EAPCI/ACVC Expert Consensus Statement on Cardiogenic Shock in Women.EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology · 2025
    Guideline
  2. Ultrasound-Guided Vascular Cannulation.Current cardiology reports · 2026
    Review
  3. Article
  4. Review
  5. Article
  6. Safety and Efficacy of a Plug-Based Vascular Closure Device After Percutaneous Microaxial Flow Pump in the Treatment of Complex and High-Risk Indicated Patients.Catheterization and cardiovascular interventions : official journal of the Society for Cardiac Angiography & Interventions · 2025
    Observational
  7. Review
  8. Article
  9. Observational
  10. Review
  11. Article
  12. Review
  13. Review
  14. Review
  15. Review
  16. Article
  17. Review
  18. Review
  19. Article
  20. Management of Stable Angina in the Older Adult Population.Circulation. Cardiovascular interventions · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

19 authors.

Abdulla A DamlujiInova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, Virginia, USA; Division of Cardiology, Johns Hopkins School of Medicine, Baltimore, Maryland, USA. Electronic address: abdulla.damluji@jhu.edu.
Behnam TehraniInova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
Shashank S SinhaInova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
Marc D SamskyNew York University School of Medicine, New York, New York, USA.
Timothy D HenryCarl and Edyth Lindner Center for Research and Education, Christ Hospital, Cincinnati, Ohio, USA.
Holger ThieleHeart Center Leipzig and Leipzig Heart Institute, Leipzig, Germany.
Nick E J WestAbbott Vascular, Santa Clara, California, USA.
Fortunato F SenatoreDivision of Cardiology and Nephrology, U.S. Food and Drug Administration, Silver Spring, Maryland, USA.
Alexander G TruesdellInova Center of Outcomes Research, Inova Heart and Vascular Institute, Falls Church, Virginia, USA.
George D DangasDivision of Cardiology, Department of Medicine, Mount Sinai Hospital, New York, New York, USA.
Nathaniel R SmilowitzNew York University School of Medicine, New York, New York, USA.
Amit P AminDartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
Adam D deVoreDuke Clinical Research Institute, Durham, North Carolina, USA.
Nader MoazamiNew York University School of Medicine, New York, New York, USA.
Joaquin E CigarroaOregon Health and Science University, Portland, Oregon, USA.
Sunil V RaoNew York University School of Medicine, New York, New York, USA.
Mitchell W KrucoffDartmouth-Hitchcock Medical Center, Lebanon, New Hampshire, USA.
David A MorrowDivision of Cardiovascular Medicine, Brigham and Women's Hospital, Boston, Massachusetts, USA.
Ian C GilchristPenn State Heart and Vascular Institute, Hershey Medical Center, Hershey, Pennsylvania, USA.

Funding

Technological Assessment and Solutions Core - RC4P30AG021334 · NIA · JOHNS HOPKINS UNIVERSITY · PI Jeremy D Walston · 2003 to 2026
$33.2M
Postdoctoral Training in Cardiovascular Clinical ResearchT32HL069749 · NHLBI · DUKE UNIVERSITY · PI MARK, DANIEL B · 2003 to 2023
$6.7M
Mechanisms of Coronary Microvascular DiseaseK23HL150315 · NHLBI · NEW YORK UNIVERSITY SCHOOL OF MEDICINE · PI SMILOWITZ, NATHANIEL ROSSO · 2020 to 2024
$948k
Frailty and Resiliency in Older Adults with Acute Myocardial InfarctionK23HL153771 · NHLBI · INOVA HEALTH CARE SERVICES · PI DAMLUJI, ABDULLA AL · 2020 to 2024
$916k
NHLBI NIH HHS K23 HL150315NHLBI NIH HHS K23 HL153771NHLBI NIH HHS T32 HL069749NIA NIH HHS P30 AG021334
6 · The paper itself

Abstract

In the United States, the frequency of using percutaneous mechanical circulatory support devices for acute myocardial infarction complicated by cardiogenic shock is increasing. These devices require large-bore vascular access to provide left, right, or biventricular cardiac support, frequently under urgent/emergent circumstances. Significant technical and logistical variability exists in device insertion, care, and removal in the cardiac catheterization laboratory and in the cardiac intensive care unit. This variability in practice may contribute to adverse outcomes observed in centers that receive patients with cardiogenic shock, who are at higher risk for circulatory insufficiency, venous stasis, bleeding, and arterial hypoperfusion. In this position statement, we aim to: 1) describe the public health impact of bleeding and vascular complications in cardiogenic shock; 2) highlight knowledge gaps for vascular safety and provide a roadmap for a regulatory perspective necessary for advancing the field; 3) propose a minimum core set of process elements, or "vascular safety bundle"; and 4) develop a possible study design for a pragmatic trial platform to evaluate which structured approach to vascular access drives most benefit and prevents vascular and bleeding complications in practice.

Indexed as

Heart-Assist DevicesMyocardial InfarctionHemorrhageHumansShock, CardiogenicTreatment OutcomeUnited Statescardiogeniccomplicationsmyocardial infarctionshockvascular access devices

Identifiers

PMID36265932
PMCPMC10312149

What Socratic holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.